Atrial dysfunction as a marker of iron cardiotoxicity in thalassemia major

Haematologica

Volumn 93, Issue 2, 2008, Pages 311-312

  Li, Walter ^a   Coates, Thomas ^a   Wood, John C ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Diastolic function; Iron overload; MRI; Systolic function; Thalassemia

Indexed keywords

IRON;

ADULT; AGED; ARTERIAL STIFFNESS; ARTICLE; CARDIOTOXICITY; ELECTROCARDIOGRAM; FEMALE; HEART DISEASE; HEART EJECTION FRACTION; HEART OUTPUT; HEART SIZE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; THALASSEMIA;

ADOLESCENT; ADULT; ATRIAL FUNCTION, LEFT; BETA-THALASSEMIA; BIOLOGICAL MARKERS; CARDIAC OUTPUT; CARDIOTOXINS; FEMALE; HEART ATRIA; HEART DISEASES; HEART VENTRICLES; HUMANS; IRON; MALE; ORGAN SIZE;

EID: 40849098727     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.11958     Document Type: Article

References (10)

1. Arbab-Zadeh A, Dijk E, Prasad A, Fu Q, Torres P, Zhang R, et al. Effect of aging and physical activity on left ventricular compliance. Circulation 2004;110:1799-805.
2. Sievers B, Kirchberg S, Addo M, Bakan A, Brandts B, Trappe HJ. Assessment of left atrial volumes in sinus rhythm and atrial fibrillation using the biplane area-length method and cardiovascular magnetic resonance imaging with TrueFISP. J Cardiovasc Magn Reson 2004;6:855-63.
3. Kremastinos DT, Tsiapras DP, Tsetsos GA, Rentoukas EI, Vretou HP, Toutouzas PK. Left ventricular diastolic Doppler characteristics in β-thalassemia major. Circulation 1993;88:1127-35.
4. Westwood MA, Wonke B, Maceira AM, Prescott E, Walker JM, Porter JB, et al. Left ventricular diastolic function compared with T2* cardiovascular magnetic resonance for early detection of myocardial iron overload in thalassemia major. J Magn Reson Imaging 2005;22:229-33.
5. Wood JC, Tyszka JM, Ghugre N, Carson S, Nelson MD, Coates TD. Myocardial iron loading in transfusion-dependent thalassemia and sickle-cell disease. Blood 2004;103:1934-6.
6. Ghugre NR, Enriquez CM, Coates TD, Nelson MD Jr, Wood JC. Improved R2* measurements in myocardial iron overload. J Magn Reson Imaging 2006;23:9-16.
7. Wood JC, Enriquez C, Powell A, Ghugre N, Nelson MD, Polzin J, et al. Single-echo versus multiple echo cardiac T2* estimates for cardiac iron estimation in iron overload. J Cardiovasc Magn Reson 2005;7:97.
8. Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 2004;89:1187-93.
9. Buja LM, Roberts WC. Iron in the heart. Etiology and clinical significance. Am J Med 1971;51:209-21.
10. Tanner MA, Galanello R, Dessi C, Smith GC, Westwood MA, Agus A, et al. A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance. Circulation 2007;115:1876-84.